8UH9
Crystal structure of SARS-CoV-2 main protease E166V mutant in complex with an inhibitor TKB-272
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SPRING-8 BEAMLINE BL41XU |
Synchrotron site | SPring-8 |
Beamline | BL41XU |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2022-07-29 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 1.0 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 113.673, 53.090, 45.774 |
Unit cell angles | 90.00, 101.96, 90.00 |
Refinement procedure
Resolution | 55.600 - 2.067 |
R-factor | 0.19413 |
Rwork | 0.192 |
R-free | 0.24028 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.008 |
RMSD bond angle | 1.470 |
Data reduction software | DIALS |
Data scaling software | DIALS |
Phasing software | MOLREP |
Refinement software | REFMAC (5.8.0419) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 55.600 | 2.100 |
High resolution limit [Å] | 2.067 | 2.067 |
Rpim | 0.108 | |
Number of reflections | 16462 | 783 |
<I/σ(I)> | 5.98 | 0.26 |
Completeness [%] | 99.5 | |
Redundancy | 6.9 | |
CC(1/2) | 0.280 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 298 | 0.4 M Sodium acetate trihydrate, pH 5.8, 30% PEG 400, 3% DMSO |